PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F11XT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $16,115
Award facts
- Contract value 100% obligated
- $16,114.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $16,114.86 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 2, 2026, with an ultimate completion date of January 5, 2026. This contract is a non-set-aside, competitively awarded delivery order utilizing firm fixed price terms. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. Under the SPE2DX prime vendor global contract, the company supplies a comprehensive range of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order exemplifies AmerisourceBergen's role in fulfilling federal medical supply requirements through the DLA's strategic pharmaceutical support vehicle, which enables the company to deliver critical medical commodities to support Defense Health Agency operations and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2D826F11XT?
SPE2D826F11XT was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 2, 2026.
How much is contract SPE2D826F11XT worth?
The government has obligated $16,115 on SPE2D826F11XT.
Is contract SPE2D826F11XT an order under another contract?
Yes. SPE2D826F11XT is a delivery order under SPE2DX22D0020, an indefinite delivery contract.
Was contract SPE2D826F11XT competed?
The extent of competition for SPE2D826F11XT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award